The relationship of cystatin C, creatinine, estimated GFR, and cardiovascular events

Abstract

This study examined the predictive value of plasma cystatin C, creatinine and estimated glomerular filtration rate (eGFR) as risk factors for cardiovascular disease in Chinese. Plasma cystatin C and creatinine were measured in 466 coronary heart disease (CHD) patients recruited from 4 hospitals and 349 healthy controls from local communities in Wuhan, China. Cockroft-Gault formula was used to estimate the glomerular filtration rate (GFR) after adjusting for body surface area. With each measure, the study population was divided into quintiles. The results showed that the patients had significantly higher levels of plasma cystatin C, creatinine, and lower level of eGFR than controls. Lower eGFR was associated with a higher risk of cardiovascular events. As compared with the first (highest) quintile, the hazard ratios (and 95% CIs) after multivariate adjustment for CHD were as follows: third quintile, 2.98 (1.54–5.78); fourth quintile, 3.34 (1.58–7.09); fifth quintile, 4.37(1.84–10.35). With higher cystatin C quintiles (≥1.00 mg/L and ≥1.17 mg/L), the hazard ratios for CHD were 2.16 (1.23–3.81) and 2.34 (1.25–4.38), similar to those of creatinine 2.21 (1.21–4.03) and 2.03 (1.07–3.84). However, it was plasma cystatin C not eGFR or creatinine had stronger association with ischemic stroke. The highest quintile had the hazard ratio of 4.51 (1.45–14.08) after multivariate adjustment. It was concluded that plasma cystatin C, associated with renal function, is not an independent risk factor for cardiovascular disease. eGFR is a better risk predictor for CHD than plasma cystatin C and creatinine. But for ischemic stroke, plasma cystatin C is a better risk factor than creatinine and estimated GFR.

Keywords

coronary heart disease / kidney function / cystatin C / stroke / glomerular filtration rate

References

[1] ShlipakM.G., FriedL.F., CushmanM., et al.. Cardiovascular mortality risk in chronic kidney disease comparison of traditional and novel risk factors. JAMA, 2005, 293(14): 1737-1745

[2] SchiffrinE.L., LipmanM.L., MannJ.F.. Chronic kidney disease: effects on the cardiovascular system. Circulation, 2007, 116(1): 85-97

[3] ShlipakM.G., KatzR., SarnakM.J., et al.. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med, 2006, 145(4): 237-246

[4] JohnstonN., JernbergT., LindahlB., et al.. Biochemical indicators of cardiac and renal function in a healthy elderly population. Clin Biochem, 2004, 37(3): 210-216

[5] WasénE., IsoahoR., MattilaK., et al.. Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C. J Intern Med, 2004, 256(1): 70-78

[6] BiZ.Q., XuH., ZhuL.Q., et al.. Evaluation of the clinical application of GFR-estimating equation in elderly patients. Chin J Geriatr, 2006, 25(1): 25-28

[7] ZuoL., MaY.C., ZhouY.H., et al.. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis, 2005, 45: 463-472

[8] ShlipakM.G., SarnakM.J., KatzR., et al.. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med, 2005, 352(20): 2049-2060

[9] ShlipakM.G., Wassel FyrC.L., ChertowG.M., et al.. Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol, 2006, 17(1): 254-261

[10] IxJ.H., ShlipakM.G., ChertowG.M., et al.. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease. Circulation, 2006, 115(2): 173-179

[11] KoenigW., TwardellaD., BrennerH., et al.. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem, 2005, 51(2): 321-327

[12] ShlipakM.G., HeidenreichP.A., NoguchiH., et al.. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med, 2002, 137(7): 555-562

[13] RuleA.D., BergstralhE.J., SlezakJ.M., et al.. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int, 2006, 69(2): 399-405

[14] BökenkampA., Herget-RosenthalS., BökenkampR.. Cystatin C, kidney function and cardiovascular disease. Pediatr Nephrol, 2006, 21(9): 1223-1230

[15] GoA.S., ChertowG.M., FanD., et al.. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med, 2004, 351(13): 1296-1305

[16] LaterzaO.F., PriceC.P., ScottM.G.. Cystatin C: an improved estimator of glomerular filtration rate. Clin Chem, 2002, 48(5): 699-707

[17] LiuJ., SukhovaG.K., SunJ.S., et al.. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol, 2004, 24(8): 1359-1366

[18] ErikssonP., DeguchiH., SamnegårdA., et al.. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler Thromb Vasc Biol, 2004, 24(3): 551-557

[19] LoewM., HoffmannM.M., KoenigW., et al.. Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events. Arterioscler Thromb Vasc Biol, 2005, 25(7): 1470-1474

[20] HeY., ChenJ.Z., WangH.P.. Relationship between polymorphisms (rs2897119 and rs6114208) in cystatin C gene promoter region and stroke risk. Mol Cardiol China, 2007, 7(4): 81-84

[21] PotterK., HankeyG.J., GreenD.J., et al.. Homocysteine or renal impairment, which is the real cardiovascular risk factor. Arterioscler Thromb Vasc Biol, 2008, 28(6): 1031-1033

[22] LucG., BardJ.M., LesueurC., et al.. Plasma cystatin C and development of coronary heart disease: the PRIME Study. Atherosclerosis, 2006, 185(2): 375-380

[23] ShlipakM.G., PraughtM.L., SarnakM.J.. Update on cystatin C: new insights into the importance of mild kidney dysfunction. Curr Opin Nephrol Hypertens, 2006, 15(3): 270-275

[24] NiL., LüJ., HouL.B., et al.. Cystatin C, associated with hemorrhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese. Stroke, 2007, 38(12): 3287-3288

[25] MaY.C., ZuoL., WangM., et al.. Comparison of MDRD equations and creatinine clearance for estimating glomerular filtration rate. J Clin Intern Med, 2006, 23(1): 32-35